Evoke Pharma Inc

NASDAQ:EVOK   3:59:43 PM EDT
3.12
+0.08 (+2.63%)
Earnings Announcements

Evoke Pharma Reports Q3 Loss Per Share $0.08

Published: 11/10/2020 13:45 GMT
Evoke Pharma Inc (EVOK) - Evoke Pharma Reports Third Quarter 2020 Financial Results.
Q3 Loss per Share $0.08.
Expects That Its Current Cash Balance Will Be Sufficient to Support Operations Into Q2 of 2021.
Revenue is expected to be $0.85 Million
Adjusted EPS is expected to be -$0.14

Next Quarter Revenue Guidance is expected to be $1.4 Million
Next Quarter EPS Guidance is expected to be -$0.06

More details on our Analysts Page.